InvestorsHub Logo
Followers 0
Posts 5690
Boards Moderated 0
Alias Born 06/09/2012

Re: None

Wednesday, 01/28/2015 5:31:22 PM

Wednesday, January 28, 2015 5:31:22 PM

Post# of 703827
DCVax-L will never be very good at treating ePD GBM patients. Nothing is. But of course this trial has naught to do with them.

DCVax-L will show strong data in psPDs. Very strong.

The 49 being randomized by Aug 2012 does not contradict my modeling.

People are very confused over the 33 (I was too for a while).

Factoring for low CD4+ count patients had nothing to do with increasing sample size.

And that's.. all I really care to say right now!

GL

I'd offer you advice, but I just don't care about your money, unless you give me money to care about your money. I might even be tricking you with the above post...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News